Ibuprom Zatoki, 12 coated tablets

Ibuprom Zatoki is a drug intended for occasional use to relieve symptoms occurring in colds and flu , such as: headache, pain and obstruction of the sinuses, runny nose, fever, sore throat, muscle pain.

In addition,  Ibuprom Zatoki is used temporarily to treat the symptoms of sinusitis, such as headache, sinus and nasal obstruction with pain, which are a consequence of complications of colds, flu or allergic rhinitis.

Ibuprom Zatoki is used on an ad hoc basis to relieve symptoms occurring in colds and flu, such as: headache, pain and obstruction of the sinuses, runny nose, fever, sore throat, muscle pain.

Ibuprom Zatoki contains:

The active substances of the drug are ibuprofen and pseudoephedrine hydrochloride.
Other excipients are: cellulose powder (Elcema P-100), cellulose powder (Elcema F-150), corn starch, pregelatinized starch, Guar gum, talc, croscarmellose sodium, crospovidone, colloidal silicon dioxide, hydrated, hydrogenated vegetable oil.
Coating composition: hydroxypropylcellulose, macrogol 400, talc, gelatin, sucrose, kaolin, confectioner’s sugar (mixture of sucrose and corn starch), calcium carbonate, Opaglos Clear GS-2-0750 (mixture of carnauba wax, white wax and ethanol denatured with methanol), gum arabic dried dispersion, corn starch, Opalux Brown AS-16518 (mixture of sucrose, titanium dioxide (E171), sunset yellow lake (E110), allura red lake (E129), indigo carmine lake (E132), povidone, sodium benzoate (E211)).
Printing ink composition: Opacode Black S-1-17823 (mixture of shellac, black iron oxide (E172), n-butyl alcohol, isopropyl alcohol, ammonium hydroxide 28%, propylene glycol, ethanol).

Adults and children over 12 years: 1 to 2 tablets orally every 4 hours after meals. Do not exceed 6 tablets per day (maximum daily dose of 1200 mg ibuprofen and 180 mg pseudoephedrine hydrochloride in divided doses). This medicinal product should not be administered to children under 12 years of age.

Elderly: No dosage adjustment is required unless renal or hepatic function is impaired. In this case, the physician should establish an individual dosage for the patient.

The lowest effective dose should be used for the shortest period necessary to relieve symptoms. If the medicinal product is required for more than 3 days or the patient’s condition worsens, the patient should contact a doctor.

The medicinal product Ibuprom Zatoki is contraindicated in patients:

• with hypersensitivity to the active substances or any of the excipients;
• who have ever had allergy symptoms such as runny nose, hives or bronchial asthma after taking acetylsalicylic acid or other non-steroidal anti-inflammatory drugs (NSAIDs);
• with active or history of gastric and/or duodenal ulcer, perforation or bleeding, including those associated with NSAID therapy;
• with bleeding diathesis;
• with severe hepatic failure, severe renal failure or severe heart failure,
• during pregnancy and breastfeeding;
• taking other non-steroidal anti-inflammatory drugs, including COX-2 inhibitors (increased risk of side effects);
• with severe cardiovascular disorders, tachycardia, arterial hypertension, angina pectoris;
• with hyperthyroidism;
• with diabetes;
• with closed-angle glaucoma;
• with prostatic hyperplasia;
• with pheochromocytoma of the adrenal gland.